Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of INFU revenue | Skew |
|---|---|---|---|
| ICUIICU Medical, Inc. | 3.86% | 60.00% | 16× |
| GEHCGE Healthcare | 0.04% | 5.50% | 144× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“ICU Medical, Inc. supplied approximately 60% of the ambulatory pumps purchased by us in 2025.”
$86M relationship16× more of INFU’s book than ICUI’s
basisINFU fy2025 · closed 2025-12 $143MICUI fy2025 · closed 2025-12 $2.2B
FILING10-K0001628280-26-012804cik 0001337013
“During 2025, we restructured our biomedical services contract with GE Healthcare and, consequently, we are starting 2026 at a reduced revenue volume of $7.1 million, or 5.5% annually.”
$8M relationship144× more of INFU’s book than GEHC’s
basisINFU fy2025 · closed 2025-12 $143MGEHC fy2025 · closed 2025-12 $20.6B
“We received accreditation from Community Health Accreditation Partner ("CHAP") on February 17, 2009 and we have remained accredited to date.”
FILING10-K0001628280-26-012804cik 0001337013
“Our fleet off NPWT devices include devices manufactured by Smith and Nephew, Cork Medical LLC ("Cork") and Genadyne Biotechnologies Inc.”
FILING10-K0001628280-26-012804cik 0001337013
“In 2024, SI Healchare entered into an exclusive distribution agreement with ChemoMouthpiece, LLC to market and sell a new product designed to reduce the incidence of Oral Mucositis in cancel patients.”
FILING10-K0001628280-26-012804cik 0001337013
“Our fleet off NPWT devices include devices manufactured by Smith and Nephew, Cork Medical LLC ("Cork") and Genadyne Biotechnologies Inc.”
FILING10-K0001628280-26-012804cik 0001337013
“In November 2022, the Company established a partnership, SI Healthcare Technologies, LLC ("SI Healthcare"), with Sanara MedTech Inc. ("Sanara").”
FILING10-K0001628280-26-012804cik 0001337013
“Our fleet off NPWT devices include devices manufactured by Smith and Nephew, Cork Medical LLC ("Cork") and Genadyne Biotechnologies Inc.”
FILING10-K0001628280-26-012804cik 0001337013
“We also contract with various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of our Medicare patients and numerous other insurance carriers.”
FILING10-K0001628280-26-012804cik 0001337013
“We are required to have a Medicare Supplier Number in order to have the ability to bill Medicare for services provided to Medicare patients.”
FILING10-K0001628280-26-012804cik 0001337013
Watchlist prices, news filtered to it, and its next report on your desk.
InfuSystem Holdings, Inc has 7 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either InfuSystem Holdings, Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
InfuSystem Holdings, Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Surgical & Medical Instruments & Apparatus
Prev close 12.16 · gapped below the open, then crossed back over prior close. High/low 12.24 at 3:30 pm ET, 12.01 at 10:30 am ET.
INFU (InfuSystem Holdings, Inc) has 7 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: GEHC +0.44%, in healthcare.